Background/Aims: A growing body of evidence indicates that the abnormal expression of microRNAs (miRNAs) play an important role in sensitizing the cellular response to ionizing radiation (IR). The aim of this study was to investigate whether the expression of miR-124 correlated with radiosensitivity in the context of non-small-cell lung carcinoma (NSCLC). Methods: Quantitative reverse transcription polymerase chain reaction (RT-PCR) was used to quantify miR-124 expression in NSCLC tissues and cell lines. The role of miR-124 in NSCLC proliferation and radiosensitivity was analyzed using CCK-8 and flow cytometry apoptosis assays. Luciferase activity assays, RT-PCR, and Western blot assays were performed to confirm the target gene of miR-124. Results: In this study, we found that miR-124 was downregulated both in clinical NSCLC samples and in cell lines. miR-124 inhibited the proliferation of NSCLC cells and enhanced the apoptosis of NSCLC cells exposed to ionizing radiation. We identified signal transducer and activator of transcription 3 (STAT3) as a direct target of miR-124 by using target prediction algorithms and luciferase assays. Overexpression of STAT3 in A549 cell lines restored the enhanced radiosensitivity induced by miR-124. Conclusion: Taking these observations into consideration, we illustrated that miR-124 is a potential target for enhancing the radiosensitivity of NSCLC cells by targeting STAT3.
Introduction
Among malignant tumors in China, lung cancer, a common type of cancer, is the leading cause of death [1] . Non-small cell lung cancer (NSCLC), the most common type of lung cancer, accounts for approximately 80% of lung cancer cases [2] . Approximately two-thirds of NSCLC patients are diagnosed after the disease is already in advanced stages [2] . Radiation therapy is a powerful tool for treating locally advanced NSCLC [3] . However, radiation resistance is an obstacle to the successful treatment of NSCLC [4] . The key mechanisms that govern tumor radiation resistance remain unclear.
MicroRNAs (miRNAs) are a class of small (∼22 nucleotides) non-coding RNA molecules that regulate gene expression by either targeting mRNA for degradation or by inhibiting mRNA translation [5] . Studies have demonstrated that miRNAs play important roles in biological processes, such as proliferation, differentiation and apoptosis. Some miRNAs have been confirmed to modulate the function of known oncogenes and tumor suppressor genes [6] . These miRNAs may be useful for predicting and modifying the effects of anticancer treatments (including chemotherapy, radiotherapy, and immunotherapy) [7, 8] . Moreover, a growing body of evidence suggests that some miRNAs are associated with radiotherapy resistance, particularly in lung cancer [9, 10] .
miR-124 is a highly conserved miRNA that has been reported to be downregulated in many human malignant tumors, including gastric cancer, breast cancer, hepatocellular carcinoma and glioblastoma [11] [12] [13] [14] [15] . Furthermore, Deng et al. found that miR-124 can radiosensitize glioblastoma multiforme cells through the miR-124/CDK4 axis [16] . However, the function of miR-124 in tumor radioresistance remains poorly understood. In the present study, we explore the role of miR-124 in radiotherapy sensitivity in NSCLC and the potential molecular mechanism.
Materials and Methods

Patient and tissue samples
The study was approved by the Research Ethics Committee of Taixing People's Hospital. Paired NSCLC and para-carcinoma tissues were taken from 12 patients who underwent radical resections for primary tumors between 2015 and 2016 at Taixing People's Hospital. All participants signed the informed consent. Tumor tissues and adjacent normal tissues were obtained immediately after the resection. Fresh tissue was snap-frozen in liquid nitrogen and subsequently transferred to −80°C for storage until further processing.
Cell lines and culture conditions
Three NSCLC adenocarcinomas cell lines (A549, NCI-H1299 and NCI-H1650) and a normal human bronchial epithelial cell line (BEAS-2B) were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). NSCLC cells and BEAS-2B cells were maintained in RPMI 1640 medium or DMEM (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS; Gibco), penicillin (100 U/ml) and streptomycin (100 µg/ml) (Beyotime Biotech, Haimen, China) in humidified air at 37°C with 5% CO 2 .
Cell transfection
The miR-124 mimics and the negative control mimics (NCs) were purchased from GenePharma (Shanghai, China) and transfected into NSCLC cells at a final concentration of 30 nmol/L. The transfection of NSCLC cells was performed with Lipofectamine® 2000 (Life Technologies, NY, USA) according to the manufacturer's protocol. For each treatment group, the experiments were performed in triplicate. Transfection with STAT3-specific siRNA (siSTAT3) was performed as described previously [15] .
RNA isolation and quantitative real-time PCR
Total RNA was extracted using TRIzol Reagent (Invitrogen, Carlsbad, CA) from the NSCLC cell lines and the tumor specimens previously stored at −80°C. First-strand cDNA was synthesized using a reverse
Cell Counting Kit-8 (CCK-8) assay
After treatment, A549 cells were seeded into a 96-well plate at a density of 1 × 10 4 cells/well and incubated for 96 hours. In vitro cell proliferation was measured using the Cell Counting Kit-8 (CCK-8) (Beyotime Biotech, Haimen, China) according to the manufacturer's instructions. The absorbance of each well at 450 nm (630 nm reference) was determined with a Multiskan FC microplate absorbance reader (Thermo Fisher, Grand Island, NY, USA). Each experiment was repeated in triplicate.
Colony formation assay
After exposure to various treatments, 200 cells were trypsinized, washed, seeded into 6-well plates and routinely cultured. Cells were grown for 14 days, fixed with ethanol, and stained with crystal violet to detect colonies. The number of colonies containing at least 50 cells was calculated.
Cell cycle analysis by flow cytometry
After a 48-h transfection period, A549 cells were trypsinized, washed with PBS and fixed in 75% ethanol at 4°C overnight. After a 24-h fixation period, the cells were washed with PBS and treated with propidium iodide (PI) stain (Beyotime Biotech) for 30 min. Cell cycle analysis was conducted with a BD FACSCanto™ II flow cytometry system with a ModFit LT software package.
Apoptosis assay
Apoptosis was evaluated using the Annexin V-FITC Apoptosis Detection Kit (Beyotime Biotech, Haimen, China) according to the manufacturer's instructions. Cells (1 × 10 5 ) were transfected with miR-124 mimics or NCs for 48 h and stained with Annexin V-FITC. Cells were resuspended in binding buffer (190 μL), followed by the addition of 10 μL of PI (20 μg/mL), and incubated for at least 15 min at room temperature in the dark. Stained cells were analyzed with a BD FACSCanto™ II flow cytometry system. Early apoptosis was measured as the percentage of Annexin V-positive/PI-negative cells.
Hoechst 33258 stain
Following the experimental treatment, NSCLC cells were treated with Hoechst 33528 (5 mg/ml; Beyotime Biotech) for 10 min in the dark and then were washed thoroughly three times with PBS. Nuclear staining was detected under an Olympus IX73 inverted fluorescence microscope (Olympus Co. Ltd., Tokyo, Japan).
Luciferase report assay The 3′-UTR sequence of STAT3 from human genomic DNA containing the predicted miR-124 binding site was amplified by PCR. The 3′-UTR segment of STAT3 with the mutated miR-124 target site was generated with a QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA). A total of 1×10 4 cells were seeded per well in 150 µl of RPMI 1640 medium. A total of 100 ng of wild-type (wild) or mutant (mut) STAT3 3′-UTR reporter plasmids were co-transfected with Lipofectamine 2000 transfection reagent into A549 cells with 30 nM miR-124 or NC according to the manufacturer's protocol. After 48 h, luciferase activity was detected with the Dual-Luciferase Reporter Assay Kit (Promega Corp., Madison, WI, USA).
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Western blot analysis
Proteins were separated by SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride (PVDF) transfer membranes (Millipore, Bedford, MA, USA). The membranes were blocked with 5% non-fat milk and incubated with the primary antibodies (rabbit anti-STAT3 monoclonal antibody or mouse anti-GAPDH monoclonal antibody; Abcam, Cambridge, MA, USA). Finally, the blots were incubated with HRP-conjugated goat anti-mouse or anti-rabbit antibody for 1.5 h at room temperature, and the blots were detected with enhanced chemiluminescence reagents (Beyotime, Haimen, China).
Statistical analysis
Data are presented as the means ± standard deviations (S.D.s) of three independent experiments. The Statistical Package for the Social Sciences for Windows Version 12.0 was used to conduct all relative analyses with either Student's t-test or two-way ANOVA. P<0.05 was considered statistically significant.
Results
MiR-124 expression is downregulated in NSCLC cell lines and tissues
Real-time PCR assays revealed that miR-124 expression was markedly decreased in all three NSCLC cell lines, including A549, NCI-H1299 and NCI-H1650 cells, compared with the expression in the normal human bronchial epithelial BEAS-2B cell line (Fig. 1A) . Moreover, comparative analysis revealed that miR-124 expression was significantly downregulated in 12 pairs of NSCLC cancerous tissues compared with that in adjacent noncancerous tissues (Fig.  1B, 1C) . Collectively, these results suggested that miR-124 was downregulated in NSCLC.
Ectopic expression of miR-124 inhibited the proliferation of NSCLC cells
To investigate the effect of miR-124 on cell proliferation, we transfected the NSCLC A549 cell line with miR-124 mimics. The increased expression of miR-124 after transfection was confirmed by quantitative real-time PCR (Fig. 2A) . CCK-8 and colony formation assays showed that ectopic expression of miR-124 markedly inhibited the proliferation and growth 
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at the dose 4 Gy (22.5 ± 2.5% versus 8.9 ± 0.9%, P < 0.05). Similar results were obtained by staining with Hoechst 33528 (Fig. 3D ). As shown in Fig. 4A and 4B, the decrease in STAT3 expression levels after transfection of the miR-124 mimics was confirmed by quantitative real-time PCR in NCI-H1299 cells. Similarly, miR-124 inhibited the proliferation and enhanced the radiosensitivity of NCI-H1299 cells ( Fig. 4C and 4D ). These results indicated that the overexpression of miR-124 may enhance the radiosensitivity of NSCLC cells and thus confirmed that miR-124 is involved in the regulation of the radiotherapy response of NSCLC.
MiR-124 directly regulates STAT3 gene expression in NSCLC cells
To investigate the target genes of miR-124, the potential targets of miR-124 were predicted using the online tool TargetScanHuman 6.2 (http://www.targetscan.org/). Our analysis revealed that STAT3 was a potential target of miR-124 (Fig. 5A) . To determine if miR-124 directly binds to the STAT3 3′UTR, a luciferase reporter gene assay was performed. A549 cells were co-transfected with luciferase reporter gene plasmids and miR-124 mimics or NCs. The miR-124 mimics, rather than the NCs, significantly inhibited the luciferase activity of the reporter gene containing the wild-type STAT3 3′UTR but did not affect the luciferase activity of the reporter gene containing the mutated STAT3 3′UTR (Fig. 5B) . RT-PCR and Western blot assays confirmed that the overexpression of miR-124 decreased STAT3 mRNA and protein expression levels (Fig. 5C, 5D , and 5E). These results suggest that STAT3 is a direct target of miR-124.
Expression of STAT3 restored the suppressive function of miR-124
We ectopically expressed recombinant STAT3 lacking the 3′-UTR sequence (pcDNA3.1-STAT3) in A549 cells. A549 cells transfected with the miR-124 mimics showed significantly 
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Cellular Physiology and Biochemistry radiosensitivity on human glioma cells [16] . In this study, we found that miR-124 expression is downregulated in NSCLC cell lines and tissues. Ectopic expression of miR-124 inhibited the proliferation of NSCLC cells and enhanced apoptosis in NSCLC cells induced by ionizing radiation. Our findings indicate that miR-124 acts as a tumor suppressor in NSCLC. In this study, by using an online tool TargetScan Release 6.2 (http://www.targetscan. org/), we predicted that STAT3 may be a direct target of miR-124. Our hypothesis was also confirmed by luciferase reporter assays, Western blotting and RT-PCR. STAT3 has been extensively demonstrated to play a critical role in the tumorigenesis of various human malignancies [25] . For example, increased activation of STAT3 is a characteristic of various tumors and tumor cell lines [26, 27] . Key gene expression changes modulated by the aberrant activation of STAT3 may promote cancer cell proliferation and survival and inhibit apoptosis [28, 29] . In addition, Xie et al. reported that STAT3 may also play a role in cancer cell invasion and metastasis [30] . An increasing amount of evidence indicates that STAT3 activation is associated with radiotherapy sensitivity. Yang et al. found that celecoxib suppresses the phosphorylation of STAT3 protein expression and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells [31] . Zhang et al. reported that the STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer cells via the downregulation of HIF-1α [32] . In this study, we found that the overexpression of miR-124 enhanced the radiosensitivity of NSCLC cells. Our study and previous studies demonstrate that STAT3 is a direct target gene of miR-124. Furthermore, we found that the expression of STAT3 restored the suppressive function of miR-124. These results indicated that the miR-124/STAT3 axis is associated with the radiosensitivity of NSCLC cells.
Conclusion
In summary, our findings in the present study demonstrated that the miR-124/STAT3 axis plays an important role in the modulation of radiation sensitivity in NSCLC cells. Thus, miR-124 and STAT3 are potential radiosensitivity associated targets for the treatment of NSCLC. Further investigation through large clinical research studies is required to determine the clinical significance of both miR-124 and STAT3.
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